oct-2-ynylamine | 206183-09-7

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: oct-2-ynylamine
• 英文别名: Oct-2-inylamin；2-Octyn-1-ylamine；oct-2-yn-1-amine
• CAS: 206183-09-7
• 化学式: C₈H₁₅N
• mdl: MFCD19208975
• 分子量: 125.214
• InChiKey: CFEQWBSLONZMTF-UHFFFAOYSA-N

物化性质

• 沸点：
  75 °C(Press: 10 Torr)
• 密度：
  0.8458 g/cm3(Temp: 420 °C)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  9
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  oct-2-ynylamine 在 乙醇 、 硫酸 、 mercury(II) sulfate 作用下， 生成 1-amino-octan-3-one
  参考文献：
  名称：

  Marszak; Koulkes, Bulletin de la Societe Chimique de France, 1956, p. 93,95

  摘要：

  DOI：
• 作为产物：
  描述：

  1-溴-2辛炔 生成 oct-2-ynylamine
  参考文献：
  名称：

  Marszak; Koulkes, Bulletin de la Societe Chimique de France, 1956, p. 93,95

  摘要：

  DOI：

文献信息

• PHOTOELECTRIC CONVERSION ELEMENT, SOLAR CELL, AND COMPOSITION
  申请人：FUJIFILM Corporation

  公开号：US20180108492A1

  公开（公告）日：2018-04-19

  Provided are a photoelectric conversion element, a solar cell using the photoelectric conversion element, and a composition. The photoelectric conversion element includes a first electrode including a photosensitive layer, which includes a light absorbing agent, on a conductive support. The light absorbing agent includes a compound having a perovskite-type crystal structure that includes organic cations represented by the following Formulae (1) and (2), a cation of a metal atom, and an anion. R 1 —N(R 1a ) 3 + Formula (1) R 2 —N(R 2a ) 3 + Formula (2) In Formulae (1) and (2), R 1 represents a specific group such as an alkyl group (including a specific substituent group in a case where the number of carbons is 1 or 2), and a cycloalkyl group. R 2 represents a methyl group, an ethyl group, and the like. R 1a and R 2a represent a specific group such as a hydrogen atom and an alkyl group.

  提供了一个光电转换元件、使用该光电转换元件的太阳能电池以及一种组合物。该光电转换元件包括第一电极，该第一电极包括一个光敏层，该光敏层包括一个吸光剂，该吸光剂包括具有钙钛矿型晶体结构的化合物，其中该晶体结构包括以下式(1)和(2)所表示的有机阳离子、金属原子的阳离子和阴离子。在式(1)和(2)中，R1代表一个特定基团，如烷基基团(在碳数为1或2时包括一个特定的取代基团)和环烷基基团。R2代表甲基基团、乙基基团等。R1a和R2a代表氢原子和烷基基团等特定基团。
• 4-Substituted-5-cyano-7-nitro-2-(.alpha.,.alpha.-difluoroalkyl)benzimidaz
  申请人：Eli Lilly and Company

  公开号：US03939166A1

  公开（公告）日：1976-02-17

  4,5-Disubstituted-7-nitro-2-(.alpha.,.alpha.-difluoroalkyl)benzimidazole compounds and their alkali metal and alkaline earth metal salts, useful as insecticides.

  4,5-二取代-7-硝基-2-(α,α-二氟烷基)苯并咪唑化合物及其碱金属和碱土金属盐，可用作杀虫剂。
• 4-Substituted piperidine analogs and their use as subtype selective NMDA receptor, antagonists
  申请人：——

  公开号：US20030105133A1

  公开（公告）日：2003-06-05

  Novel 4-substituted piperidine analogs, pharmaceutical compositions containing the same and the method of using 4-substituted piperidine analogs as selectively active antagonists of N-methyl-D-aspartate (NMDA) receptor subtypes for treating conditions such as stroke, cerebral ischemia, central nervous system trauma, hypoglycemia, anxiety, convulsions, aminoglycoside antibiotics-induced hearing loss, migraine headaches, glaucoma, CMV retinitis, chronic pain, opioid tolerance or withdrawals, or neurodegenerative disorders, such as lathyrism, Alzheimer's Disease, Parkinsonism and Huntington's Disease are described. Also described are novel methods for preparing 4-substituted piperidine analogs and novel intermediates of the 4-substituted piperidine analogs.

  本文介绍了新型4-取代哌啶类似物、含有相同成分的制药组合物以及使用4-取代哌啶类似物作为选择性活性N-甲基-D-天门冬氨酸（NMDA）受体亚型拮抗剂治疗中风、脑缺血、中枢神经系统创伤、低血糖、焦虑、惊厥、氨基糖苷类抗生素引起的听力损失、偏头痛、青光眼、巨细胞病毒性视网膜炎、慢性疼痛、阿片类耐受或戒断综合征或神经退行性疾病，如拉蒂病、阿尔茨海默病、帕金森病和亨廷顿病的条件。还介绍了制备4-取代哌啶类似物的新方法和4-取代哌啶类似物的新中间体。
• Method for producing propargylamine compounds
  申请人：SUMITOMO CHEMICAL COMPANY, LIMITED

  公开号：EP0810199A1

  公开（公告）日：1997-12-03

  A method for producing a propargylamine compound represented by the general formula (I): which comprises reacting a propargyl compound represented by the general formula (II): with an aromatic aldehyde represented by the general formula (III):         ArCHO     (III) and ammonia to obtain an imine compound represented by the general formula (IV): and hydrolyzing the resultant imine compound. It is to provide a method for producing a propargylamine compound from a propargyl compound by a simple operation without using a special facility, using ammonia as a reaction reagent, without producing a dipropatygylamine compound and a tripropargylamine compound as by-products.

  一种生产通式(I)所代表的丙炔胺化合物的方法： 其中包括将通式（II）所代表的丙炔化合物 与通式（III）代表的芳香醛反应： ArCHO (III) 和氨反应，得到通式（IV）代表的亚胺化合物： 并水解得到的亚胺化合物。本发明的目的是提供一种不使用特殊设备、以氨为反应试剂、通过简单操作从丙炔化合物制备丙炔胺化合物的方法，该方法不会产生二丙炔胺化合物和三丙炔胺化合物作为副产品。
• PSYCHOACTIVE PROPARGYLAMINE DERIVATIVES
  申请人：UNIVERSITE DE MONTREAL

  公开号：EP0636021B1

  公开（公告）日：1998-08-05